Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Cancer

• Publication date

  1987-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19870215)59:4<748::AID-CNCR2820590414>3.0.CO;2-EPMID 3802033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan.

  1983cited by this paper
• Acute promyelocytic leukaemia: a study of 39 cases with identification of a hyperbasophilic microgranular variant

  1982cited by this paper
• Antithrombin III and anti‐activated factor × activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin

  1982cited by this paper
• Prophylactic heparin therapy in acute promyelocytic leukemia

  1978cited by this paper
• Acute promyelocytic leukemia: A review of literature

  1978cited by this paper
• Tissue Thromboplastin in Leukocytes from Various Leukemias and its Localization by Immuno-Peroxidase Staining Method

  1977cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper
• Properties of canine tissue thromboplastins from brain, lung, arteries, and veins.

  1975cited by this paper
• ACUTE PROMYELOCYTIC LEUKAEMIA: HAEMORRHAGIC MANIFESTATION AND MORPHOLOGIC CRITERIA

  1975cited by this paper
• The Procoagulant Factor of Leukaemic Promyelocytes: Demonstration of Immunologic Cross Reactivity with Human Brain Tissue Factor

  1975cited by this paper
• Heparin therapy: A simpler test of control

  1974cited by this paper
• Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic Leukaemia

  1973cited by this paper
• Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia.

  1972cited by this paper
• Antithrombin III, Antifactor Xa and Heparin

  1970cited by this paper
• Antithrombin 3, antifactor Xa and heparin.

  1970cited by this paper
• Characteristics and lipid requirements of coagulant proteins extracted from lung and brain: the specifity of protein component of tissue factor.

  1969cited by this paper
• Control of Heparin Therapy With Activated Partial Thromboplastin Times

  1967cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• HYPOFIBRINOGENEMIC HEMORRHAGE IN ACUTE MYELOGENOUS LEUKEMIA TREATED WITH HEPARIN. WITH AUTOPSY FINDINGS OF WIDESPREAD INTRAVASCULAR CLOTTING.

  1964cited by this paper
• Thromboplastic Activity of Leukemic White Cells.∗

  1954cited by this paper

• Clinical outcomes of therapeutic leukapheresis in acute promyelocytic leukemia: A single-center retrospective cohort study.

  2023cites this paper
• Disseminated intravascular coagulation in children with cancer: A systematic review

  2020cites this paper
• Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patients

  2019cites this paper
• Retrospective evaluation of 4 methods for outcome prediction in overt disseminated intravascular coagulation in dogs (2009–2014): 804 cases

  2018cites this paper
• Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases

  2018cites this paper
• Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study

  2015cites this paper
• Thrombocytopenia in cancer patients.

  2014cites this paper
• Factor VII Light Chain-Targeted Lidamycin Shows Intensified Therapeutic Efficacy for Liver Cancer

  2012cites this paper
• Prevention and Treatment of Venous and Arterial Thrombosis in Patients with Specific Conditions: Diabetes, Hypercoagulable States, Pregnancy, and Renal Insufficiency

  2012cites this paper
• Factor VII-Targeted Photodynamic Therapy for Breast Cancer and Its Therapeutic Potential for Other Solid Cancers and Leukemia

  2011influential citation
• Pathogenesis and Treatment of Thrombohemorrhagic Diathesis

  2011cites this paper
• Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer

  2011cites this paper
• Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy

  2011cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Pathogenesis and Treatment O Promyelocytic Leukemia

  2011cites this paper
• Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy.

  2011cites this paper
• promyelocytic leukemia activities of cultured blast cells from patients with acute Effect of all-trans retinoic acid on procoagulant and fibrinolytic

  2011cites this paper
• Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice

  2010cites this paper
• Disseminated Intravascular Coagulation (DIC) in cancer.

  2009cites this paper
• Avaliação da citogenética convencional e molecular em portadores de leucemia promielocítica aguda no Serviço de Hematologia do Hospital das Clínicas da Faculdade de Medicina da USP

  2009cites this paper
• Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

  2009cites this paper
• Platelet granule secretion continuously prevents intratumor hemorrhage.

  2008cites this paper
• Alternativ gespleißter humaner Tissue Factor: Klonierung, Expression und Untersuchung der prokoagulatorischen Aktivität

  2008cites this paper
• The cancer stem cell: Evidence for its origin as an injured autoreactive T Cell

  2006cites this paper
• Haemostatic problems in acute promyelocytic leukaemia.

  2006cites this paper
• Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.

  2005cites this paper
• Hemostatic alterations in cancer patients

  2005cites this paper
• Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients

  2005cites this paper
• Desintegrinas de Bothrops alternatus: biologia molecular, estudos in vitro, in vivo e bioinformática estrutural.

  2005cites this paper
• Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.

  2003cites this paper
• The hypercoagulable state of malignancy: pathogenesis and current debate.

  2002cites this paper
• Disseminated Intravascular Coagulation in Acute Leukemia

  2001cites this paper
• Pathogenesis of Thrombosis in Patients with Malignancy

  2001cites this paper
• Molecular basis for the relationship between thrombosis and cancer.

  2001cites this paper
• Regulation of Tissue Factor Expression in Myeloid and Monocytic Leukaemia Cells

  2001cites this paper
• Coagulopathy of Acute Promyelocytic Leukemia

  2001cites this paper
• Cancer and thrombosis revisited.

  2001cites this paper
• Tumorwachstum und Hämostase

  2000cites this paper
• The role of RAR and RXR activation in retinoid-induced tissue factor suppression

  2000cites this paper
• Pathophysiology of the Thrombophilic State in the Cancer Patient

  1999cites this paper
• Cell membrane lipids as experimental therapeutic targets

  1999cites this paper
• The Role of the Plasminogen Activation System in Cancer

  1999cites this paper
• The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.

  1998cites this paper
• The Impact of All-trans-Retinoic Acid on the Coagulopathy of Acute Promyelocytic Leukemia

  1998cites this paper
• Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells.

  1998cites this paper
• Disseminated intravascular coagulation in acute lymphoblastic leukemia at presentation and in early phase of remission induction therapy

  1998cites this paper
• The role of von Willebrand factor in the hemostatic defect of acute promyelocytic leukemia.

  1998cites this paper
• Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance.

  1998cites this paper
• The role of von Willebrand factor in the hemostatic defect of acute promyelocytic leukemia.

  1998cites this paper
• Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy

  1998cites this paper
• Hemostatic defects in cancer patients.

  1997cites this paper
• Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia

  1997cites this paper
• Elevated levels of tissue factor pathway inhibitor in acute non-lymphoblastic leukemia patients with disseminated intravascular coagulation.

  1997cites this paper
• Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).

  1997cites this paper
• Long-term Follow-up of Hemostatic Molecular Markers during Remission Induction Therapy with All-Trans Retinoic Acid for Acute Promyelocytic Leukemia

  1997cites this paper
• Tissue Factor (TF) and Urokinase Plasminogen Activator Receptor (uPAR) and Bleeding Complications in Leukemic Patients

  1997influential citation
• Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.

  1997cites this paper
• Symptomatic intracranial haemorrhage in acute nonlymphoblastic leukaemia: analysis of CT and autopsy findings

  1997cites this paper
• Markers of Thrombosis and Fibrinolysis

  1997cites this paper
• Clinical Aspects of Acute Promyelocytic Leukemia and Response to Retinoid Therapy

  1996cites this paper
• Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.

  1996cites this paper
• Acute promyelocytic leukaemia in the alltrans retinoic acid era

  1996influential citation
• Regulatory Mechanisms in Maintenance and Modulation of Transmembrane Lipid Asymmetry: Pathophysiological Implications

  1996cites this paper
• Coagulation disorders in cancer.

  1996cites this paper
• Changes of Tissue Factor and Thrombomodulin Levels in Isolated Leukemic Cells from a Patient with Acute Promyelocytic Leukemia during All-trans Retinoic Acid Therapy

  1996cites this paper
• Tissue Factor Expression in Human Leukocytes and Tumor Cells

  1995cites this paper
• Tissue factor: regulation of activity by flow and phospholipid surfaces.

  1995cites this paper
• Disseminated intravascular coagulation in acute leukaemias at first diagnosis

  1995cites this paper
• Recurrent venous thrombosis as the presenting manifestation of acute lymphocytic leukemia: leukemic cell procoagulant activity is not responsible for the hypercoagulable state.

  1995cites this paper
• Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.

  1995cites this paper
• Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.

  1995cites this paper
• Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.

  1994cites this paper
• Tissue factor in plasma of patients with disseminated intravascular coagulation

  1994cites this paper
• Cellular mechanisms for the activation of blood coagulation.

  1994cites this paper
• Prediction of disseminated intravascular coagulation in patients with leukemia.

  1994cites this paper
• Bleeding Tendency in Acute Promyelocytic Leukemia: Reversal by Cell Differentiation?

  1993cites this paper
• Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo

  1993cites this paper
• Cancer cell procoagulants and their implications.

  1992cites this paper
• Cancer Cell Procoagulants and Their Role in Malignant Disease

  1992cites this paper
• Modulation of tissue factor on human monocytes by cisplatin and adriamycin

  1992cites this paper
• Pathways of Coagulation/Fibrinolysis Activation in Malignancy

  1992cites this paper
• Immunohistochemical identification of tissue factor in solid tumors

  1992cites this paper
• Hemostatic alterations in cancer patients.

  1992cites this paper
• Pathogenetic Linkages between Gram Negative Septic Shock and the Cellular Initiation and Regulation of Coagulation

  1991cites this paper
• Influence of cytostatic treatment on the coagulation system and fibrinolysis in patients with non‐Hodgkin's lymphomas and acute leukemias

  1991cites this paper
• Tissue Factor Released from Leukemic Cells

  1991cites this paper
• Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia

  1991cites this paper
• Hochdosierte Antithrombin III-Therapie bei akuter myeloischer Leukämie (FAB M4 und M5) mit Verbrauchskoagulopathie

  1991cites this paper
• Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: Activation of blood coagulation, fibrinolysis and unspecific proteolysis

  1990cites this paper
• Disseminated intravascular coagulation due to malignancy.

  1990cites this paper
• One-stage method for assay of tissue factor activity of leukemic cell with special reference to disseminated intravascular coagulation.

  1990cites this paper
• Induction of macrophage procoagulant expression by cisplatin, daunorubicin and doxorubicin

  1990cites this paper
• Procoagulant activity of human stomach and colon cancers.

  1990cites this paper
• The coagulopathy of childhood leukemia thrombin activation or primary fibrinolysis?

  1990cites this paper
• Cancer Procoagulant in Acute Non Lymphoid Leukemia: Relationship of Enzyme Detection to Disease Activity

  1990cites this paper
• Cancer procoagulant in acute lymphoblastic leukemia

  1990cites this paper
• What's new in the causes of hemorrhage in acute myelogenous leukemia?

  1990cites this paper
• Acute myeloblastic leukemia with extensive erythrophagocytosis mimicking malignant histiocytosis.

  1989cites this paper
• Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiation.

  1989cites this paper
• Clinical Aspects of Disseminated Intravascular Coagulation: A Clinician's Point of View

  1989cites this paper
• Blood coagulation changes in rats during development of epithelioma.

  1989cites this paper